DUBLIN, April 26, 2016 /PRNewswire/ -- Jazz
Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will
report its 2016 first quarter financial results on Tuesday, May 10, 2016, after the close of the
financial markets. Company management will host a live audio
webcast immediately following the announcement at 4:30 p.m. EDT/9:30 p.m.
IST to discuss first quarter 2016 financial results and
provide a business and financial update.
Interested parties may access the live audio webcast via the
Investors section of the Jazz Pharmaceuticals website at
www.jazzpharmaceuticals.com. Please connect to the website prior to
the start of the conference call to ensure adequate time for any
software downloads that may be necessary to listen to the webcast.
A replay of the webcast will be archived on the website for one
week.
Audio webcast/conference call:
U.S. Dial-In Number:
+1 855 353 7924
International Dial-In Number: +1 503 343 6056
Passcode: 90587993
A replay of the conference call will be available through
May 17, 2016 and accessible through
one of the following telephone numbers, using the passcode
below:
Replay U.S. Dial-In Number: +1 855 859 2056
Replay International Dial-In Number: +1 404 537 3406
Passcode: 90587993
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc
(Nasdaq: JAZZ) is an international biopharmaceutical company
focused on improving patients' lives by identifying, developing and
commercializing meaningful products that address unmet medical
needs. The company has a diverse portfolio of products and product
candidates, with a focus in the areas of sleep and
hematology/oncology. In these areas, Jazz Pharmaceuticals markets
Xyrem® (sodium oxybate) oral solution, Erwinaze® (asparaginase
Erwinia chrysanthemi) and Defitelio® (defibrotide sodium) in
the U.S. and markets Erwinase® and Defitelio® (defibrotide) in
countries outside the U.S. For more information, please visit
www.jazzpharmaceuticals.com.
Jazz
Pharmaceuticals Contacts:
|
Investors:
Kathee
Littrell
Vice President,
Investor Relations
Ireland, +353 1 634
7887
U.S., +1 650 496
2717
|
Media:
Laurie
Hurley
Vice President,
Corporate Affairs
Ireland, +353 1 634
7894
U.S., +1 650 496
2796
|
Logo - http://photos.prnewswire.com/prnh/20150930/272253LOGO